Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pseudohypoparathyroidism Type 1A: early-phase trial registry
1 of 2 indexed Pseudohypoparathyroidism Type 1A trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Pseudohypoparathyroidism Type 1A: 2 US clinical trials tracked, 1 recruiting.
Pseudohypoparathyroidism Type 1A is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Connecticut Children's Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition pseudohypoparathyroidism-type-1a
OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Pseudohypoparathyroidism Type 1A lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pseudohypoparathyroidism Type 1A on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pseudohypoparathyroidism Type 1A is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
Connecticut Children's Medical Center
NCT00209235
Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old
Vanderbilt University Medical Center
NCT04551170
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pseudohypoparathyroidism Type 1A records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pseudohypoparathyroidism Type 1A trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pseudohypoparathyroidism Type 1A page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Pseudohypoparathyroidism Type 1A trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Connecticut Children's Medical Center sponsors the most Pseudohypoparathyroidism Type 1A trials on record, review their full trial history before evaluating a specific study. See Connecticut Children's Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pseudohypoparathyroidism Type 1A condition card totals 2 registered trials; most-linked intervention Neurocognitive and psychosocial testing; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.